TY - JOUR
T1 - Association between alcohol intake pattern and metabolic syndrome components and simulated change by alcohol intake reduction
T2 - A cross-sectional study from the Japan Multi-Institutional Collaborative Cohort Study
AU - J-MICC Study Group
AU - Shimoshikiryo, Ippei
AU - Ibusuki, Rie
AU - Shimatani, Keiichi
AU - Nishimoto, Daisaku
AU - Takezaki, Toshiro
AU - Nishida, Yuichiro
AU - Shimanoe, Chisato
AU - Hishida, Asahi
AU - Tamura, Takashi
AU - Okada, Rieko
AU - Kubo, Yoko
AU - Ozaki, Etsuko
AU - Matsui, Daisuke
AU - Suzuki, Sadao
AU - Nakagawa-Senda, Hiroko
AU - Kuriki, Kiyonori
AU - Kita, Yoshikuni
AU - Takashima, Naoyuki
AU - Arisawa, Kokichi
AU - Uemura, Hirokazu
AU - Ikezaki, Hiroaki
AU - Furusyo, Norihiro
AU - Oze, Isao
AU - Koyanagi, Yuriko N.
AU - Mikami, Haruo
AU - Nakamura, Yohko
AU - Naito, Mariko
AU - Wakai, Kenji
N1 - Funding Information:
This work was supported by Grants-in-Aid for Scientific Research on Priority Areas of Cancer (No. 17015018 ) and Innovative Areas (No. 221S0001 ) and by JSPS KAKENHI Grant Number JP16H06277 (CoBiA) from the Japanese Ministry of Education, Culture, Sports, Science and Technology .
Publisher Copyright:
© 2020 The Author(s)
PY - 2020/12
Y1 - 2020/12
N2 - To investigate the association between alcohol intake pattern in amount and frequency and metabolic syndrome (Mets) components, we simulated the change in the prevalence of Mets components by intake reduction. In order to manage Mets, alcohol intake reduction with moderation of intake pattern is required. However, evidence investigating the comparative impact of alcohol intake reduction in amount and frequency for Mets components is limited. We conducted a large-scale cross-sectional study in the general Japanese population. The study subjects included 37,371 non-drinkers and current drinkers recruited in the Japan Multi-Institutional Collaborative Cohort Study. Odds ratios (ORs) for Mets components according to alcohol intake amount and frequency were estimated using a multiple logistic regression model. The prevalence of Mets components was estimated after assumed alcohol intake reduction of a) none, b) 10 g/day (men) or 5 g/day (women), c) 20 g/day (men) or 10 g/day (women), d) less than 20 g/day (men) or 10 g/day (women) for moderate-to-heavy drinkers, e) 1–2 times/week, and f) 3–4 times/week. The ORs with alcohol intake amount and frequency increased with high blood pressure while decreasing with dyslipidemia. A J-shaped association was observed between intake amount and Mets. The estimated prevalence (%) of high blood pressure and dyslipidemia in men were a) 45.2, b) 43.0, c) 41.4, d) 40.4, e) 42.9, and f) 42.0; and a) 50.3, b) 51.8, c) 52.9, d) 50.2, e) 52.7, and f) 53.4 in women. The estimated prevalence of high blood pressure in women did not evidently decrease. Simulated alcohol intake reduction showed decreased prevalence for high blood pressure and increased prevalence for dyslipidemia in men after reduced intake amount and frequency. The largest decreased prevalence for high blood pressure was observed in men when all moderate-to-heavy drinkers reduced their alcohol intake amount to less than 20 g/day.
AB - To investigate the association between alcohol intake pattern in amount and frequency and metabolic syndrome (Mets) components, we simulated the change in the prevalence of Mets components by intake reduction. In order to manage Mets, alcohol intake reduction with moderation of intake pattern is required. However, evidence investigating the comparative impact of alcohol intake reduction in amount and frequency for Mets components is limited. We conducted a large-scale cross-sectional study in the general Japanese population. The study subjects included 37,371 non-drinkers and current drinkers recruited in the Japan Multi-Institutional Collaborative Cohort Study. Odds ratios (ORs) for Mets components according to alcohol intake amount and frequency were estimated using a multiple logistic regression model. The prevalence of Mets components was estimated after assumed alcohol intake reduction of a) none, b) 10 g/day (men) or 5 g/day (women), c) 20 g/day (men) or 10 g/day (women), d) less than 20 g/day (men) or 10 g/day (women) for moderate-to-heavy drinkers, e) 1–2 times/week, and f) 3–4 times/week. The ORs with alcohol intake amount and frequency increased with high blood pressure while decreasing with dyslipidemia. A J-shaped association was observed between intake amount and Mets. The estimated prevalence (%) of high blood pressure and dyslipidemia in men were a) 45.2, b) 43.0, c) 41.4, d) 40.4, e) 42.9, and f) 42.0; and a) 50.3, b) 51.8, c) 52.9, d) 50.2, e) 52.7, and f) 53.4 in women. The estimated prevalence of high blood pressure in women did not evidently decrease. Simulated alcohol intake reduction showed decreased prevalence for high blood pressure and increased prevalence for dyslipidemia in men after reduced intake amount and frequency. The largest decreased prevalence for high blood pressure was observed in men when all moderate-to-heavy drinkers reduced their alcohol intake amount to less than 20 g/day.
UR - http://www.scopus.com/inward/record.url?scp=85094214635&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094214635&partnerID=8YFLogxK
U2 - 10.1016/j.alcohol.2020.09.002
DO - 10.1016/j.alcohol.2020.09.002
M3 - Article
C2 - 32991979
AN - SCOPUS:85094214635
SN - 0741-8329
VL - 89
SP - 129
EP - 138
JO - Alcohol
JF - Alcohol
ER -